Bowel (colorectal) cancer, Colon cancer, Secondary cancers
Open
Phase 4
This trial is looking at to see if cetuximab and panitumumab could help more people.
It is for people who have bowel cancer:
that started on the right side of the bowel
that has spread. This is advanced or metastatic cancer.
with a normal RAS gene in the bowel cancer cells
Depending on the levels of biomarkers, you may have treatment as part of this trial.
Recruitment start: 25 April 2022
Recruitment end: 30 September 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jenny Seligmann Professor Richard Adams
University of Leeds
National Institute for Health Research (NIHR) Efficacy and Mechanism Evaluation (EME) Programme
Last reviewed: 02 Sept 2025
CRUK internal database number: 18059
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
